Avacta Group (AVCT) Competitors GBX 46.61 +2.36 (+5.33%) (As of 11:52 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines AVCT vs. SLN, OXB, PRTC, HZD, VRP, BVXP, ARIX, 4BB, HVO, and FARNShould you be buying Avacta Group stock or one of its competitors? The main competitors of Avacta Group include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), Arix Bioscience (ARIX), 4basebio (4BB), hVIVO (HVO), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry. Avacta Group vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix Arix Bioscience 4basebio hVIVO Faron Pharmaceuticals Oy Silence Therapeutics (LON:SLN) and Avacta Group (LON:AVCT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment, institutional ownership and community ranking. Is SLN or AVCT more profitable? Silence Therapeutics has a net margin of 0.00% compared to Avacta Group's net margin of -114.45%. Silence Therapeutics' return on equity of 0.00% beat Avacta Group's return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A Avacta Group -114.45%-73.02%-21.80% Does the MarketBeat Community favor SLN or AVCT? Avacta Group received 9 more outperform votes than Silence Therapeutics when rated by MarketBeat users. However, 68.81% of users gave Silence Therapeutics an outperform vote while only 67.30% of users gave Avacta Group an outperform vote. CompanyUnderperformOutperformSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% Avacta GroupOutperform Votes21267.30% Underperform Votes10332.70% Which has better valuation and earnings, SLN or AVCT? Silence Therapeutics has higher earnings, but lower revenue than Avacta Group. Avacta Group is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M42.34N/A-£48.60-11.01Avacta Group£22.62M7.33-£25.89M-£0.09-514.44 Does the media refer more to SLN or AVCT? In the previous week, Silence Therapeutics had 3 more articles in the media than Avacta Group. MarketBeat recorded 3 mentions for Silence Therapeutics and 0 mentions for Avacta Group. Avacta Group's average media sentiment score of 1.17 beat Silence Therapeutics' score of 0.67 indicating that Avacta Group is being referred to more favorably in the news media. Company Overall Sentiment Silence Therapeutics Positive Avacta Group Positive Do insiders & institutionals believe in SLN or AVCT? 10.2% of Avacta Group shares are owned by institutional investors. 32.9% of Avacta Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummarySilence Therapeutics beats Avacta Group on 7 of the 13 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVCT vs. The Competition Export to ExcelMetricAvacta GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£165.89M£164.72M£5.03B£1.38BDividend Yield3.97%3.25%5.16%11.73%P/E Ratio-514.44329.48135.411,551.05Price / Sales7.3314,950.821,160.97212,243.28Price / Cash15.0011.6733.5332.93Price / Book3.317.114.672.81Net Income-£25.89M-£18.52M£119.07M£152.70M7 Day Performance-0.43%-0.29%-1.83%-0.34%1 Month Performance-27.54%8.30%-3.60%7.29%1 Year Performance-64.92%26.25%31.66%91.93% Avacta Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVCTAvacta GroupN/AGBX 46.61+5.3%N/A-67.2%£167.00M£22.62M-517.89120News CoveragePositive NewsSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100High Trading VolumeOXBOxford Biomedica0.9962 of 5 starsGBX 412.50flatGBX 433.33+5.1%+113.7%£434.61M£97.28M-287.15891Gap DownHigh Trading VolumePRTCPureTech HealthN/AGBX 162+0.1%N/A-5.6%£387.86M£3.33M-702.61300HZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,710-1.1%N/A-5.2%£193.66M£13.60M2,298.1612ARIXArix BioscienceN/AGBX 142flatN/A+29.1%£183.73M£14.16M1,290.9194BB4basebioN/AGBX 1,310+0.8%N/A+146.8%£167.81M£311,000.00-1,666.67101Insider TradeNews CoverageHVOhVIVON/AGBX 22.95+3.8%N/AN/A£156.15M£67.21M724.17N/ANews CoverageFARNFaron Pharmaceuticals OyN/AGBX 143.50-2.7%N/A-44.3%£150.13M£-725,000.00-462.5034 Related Companies and Tools Related Companies Silence Therapeutics Alternatives Oxford Biomedica Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Bioventix Alternatives Arix Bioscience Alternatives 4basebio Alternatives hVIVO Alternatives Faron Pharmaceuticals Oy Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:AVCT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
